John Hovanesian is an Ophthalmology physician affiliated with Harvard Eye Associates. OpenAlex indexes 90 publications with 1,438 citations (h-index 22); ClinicalTrials.gov lists 20 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
23961 Calle De La Magdalena Ste 300
Laguna Hills, CA 926533665
Telephone
949-951-2020Provider last certified this registry record 15 Mar 2023.
Clinical trials
- 2311 TURGOR Study -Surgical Efficiency and Postoperative Corneal Clarity With Near Physiologic vs High IOP Settings
Sponsor: Research Insight LLC
- The COAT Trial: Cequa's Onset of Action Trial
Sponsor: Research Insight LLC
- The THINK Study Incidence of Neurotrophic Keratopathy)
Sponsor: Research Insight LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202525 payments$19,603openpaymentsdata.cms.gov ↗
- Alcon Research LLCProgram year20259 payments$17,649openpaymentsdata.cms.gov ↗
- Bausch & Lomb Americas Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
95.1%Corticosteroid39.3%Prednisolone Acetate100%Part D≥74 patientsNonsteroidal Anti-inflammatory Drug33%Prolensa64%Bromfenac Sodium36%Part D≥38 patients+ 2 more classes in this area
Musculoskeletal
4.9%Cyclooxygenase Inhibitor4.9%Ketorolac Tromethamine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reducing ophthalmic surgical waste through electronic instructions for use: a multisociety position paper
Journal of Cataract & Refractive Surgery
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”